In parallel, as financing allows, CorInnova intends to conduct animal studies to evaluate their technology for Diastolic Heart Failure patients as well as for heart recovery for a Cardiac Rehabilitation indication. Driver images shown are based on actual pneumatic drivers with similar requirements. Portable driver will be roughly size of Syncardia total artificial heart portable pneumatic driver. Later development will focus on a trancutaneously powered driver, which would eliminate driveline infections, the main remaining significant adverse events after blood-contacting adverse events, such as stroke and bleeding requiring transfusions.
Conceptual image of device with portable (long-term use, right image) driver.